Anti-CLDN9 Reference Antibody (Daiichi Sankyo patent anti-CLDN9)
Produktgrößen
100 ug
£385,00
CHB947-100UG
1 mg
£965,00
CHB947-1MG
Über dieses Produkt
- SKU:
- CHB947
- Zusätzliche Namen:
- Daiichi Sankyo patent anti-CLDN9
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Anti-CLDN9 Reference Antibody (Daiichi Sankyo patent anti-CLDN9)(CHB947) is expressed from CHO. The heavy chain type is IgG1-LALA-REM, and the light chain type is kappa. It has a predicted MW of 145.54 kDa.
- Immunogen:
- CLDN9
- Isotyp:
- IgG1
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Spezifität:
- CLDN9
- Lagerbedingungen:
- 2-8[o]C, -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Recombinant Antibodies
- Datenblatt des Herstellers:CHB947